CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large‐scale international multicenter study
Year: 2015
Type: article
Study design: Observational Study
Abstract: INTRODUCTION: The aim of this study was to test the diagnostic value of cerebrospinal fluid (CSF) beta-amyloid (Aβ1-42), phosphorylated tau, and total tau (tau) to discriminate Alzheimer's disease (AD) dementia from other forms of dementia. METHODS: A total of 675 CSF samples collected at eight memory clinics were obtained from healthy controls, AD dementia, subjective memory impairment, mild cognitive impairment, vascular dementia, Lewy body dementia (LBD), fronto-temporal dementia (FTD), depression, or other neurological diseases. RESULTS: CSF Aβ1-42 showed the best diagnostic accuracy among the CSF biomarkers. At a sensitivity of 85%, the specificity to differentiate AD dementia against other diagnoses ranged from 42% (for LBD, 95% confidence interval or CI = 32-62) to 77% (for FTD, 95% CI = 62-90). DISCUSSION: CSF Aβ1-42 discriminates AD dementia from FTD, but shows significant overlap with other non-AD forms of dementia, possibly reflecting the underlying mixed pathologies.
Source: Alzheimer s & Dementia
Institutions: Institut für Schlaganfall- und Demenzforschung, Ludwig-Maximilians-Universität München, University of California, San Francisco, Sahlgrenska University Hospital, University of California San Francisco Medical Center, University of Gothenburg, Lund University, Pasqual Maragall Foundation, University of Bonn, Centre Hospitalier Universitaire Vaudois, University of Eastern Finland, Kuopio University Hospital, German Center for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Universitätsklinikum Tübingen, University Hospital of Basel, Universitäre Psychiatrische Kliniken Basel, Tottori University, Pitié-Salpêtrière Hospital, AXA Research Fund, Institut du Cerveau, Université Pierre-et-Marie-Curie
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1077156815, Industrial Academic Initial Training Network towards focused treatment of age-related motor symptoms, SENSE-PARK: Supporting and Empowering Parkinson patients in their home environment using a Novel SEnsory information system that monitors daily-life-relevant parameters of PARKinson disease and their, G3858951504, G4660350362, G6117065144
OpenAlex ID: W1991600017
